Gene Therapy for the Masses?
Gene Therapy for the Masses? https://pediatricsnationwide.org/wp-content/uploads/2024/02/04-gideonrecievesgenetherapy-1024x683.jpg 1024 683 Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gif
Long-lived financial and logistical hurdles make bringing new gene therapy products to market a major challenge. To help bring more of these medical miracles to fruition, experts across industry, regulatory review, science and medicine have begun to problem solve together. With the approval of the gene therapy Kymriah® (tisagenlecleucel) in 2017, the Food and Drug…